Sign In
Buy SCGPY
Serco Group Earnings Calls
| Release date | Mar 05, 2026 |
| EPS estimate | - |
| EPS actual | $0.0732 |
| Revenue estimate | - |
| Revenue actual | 3.329B |
| Release date | Aug 07, 2025 |
| EPS estimate | - |
| EPS actual | $0.117 |
| Revenue estimate | - |
| Revenue actual | 3.296B |
| Release date | Feb 27, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0464 |
| Revenue estimate | - |
| Revenue actual | 3.038B |
| Release date | Aug 01, 2024 |
| EPS estimate | - |
| EPS actual | $0.0972 |
| Revenue estimate | - |
| Revenue actual | 2.986B |
Last 4 Quarters for Serco Group
Below you can see how SCGPY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 01, 2024 |
| Price on release | $2.52 |
| EPS estimate | - |
| EPS actual | $0.0972 |
| Date | Price |
|---|---|
| Jul 26, 2024 | $2.52 |
| Jul 29, 2024 | $2.52 |
| Jul 30, 2024 | $2.52 |
| Jul 31, 2024 | $2.52 |
| Aug 01, 2024 | $2.52 |
| Aug 02, 2024 | $2.52 |
| Aug 05, 2024 | $1.77 |
| Aug 06, 2024 | $1.77 |
| Aug 07, 2024 | $1.77 |
| 4 days before | 0% |
| 4 days after | -29.76% |
| On release day | 0% |
| Change in period | -29.76% |
| Release date | Feb 27, 2025 |
| Price on release | $2.10 |
| EPS estimate | - |
| EPS actual | -$0.0464 |
| Date | Price |
|---|---|
| Feb 21, 2025 | $2.10 |
| Feb 24, 2025 | $2.10 |
| Feb 25, 2025 | $2.10 |
| Feb 26, 2025 | $2.10 |
| Feb 27, 2025 | $2.10 |
| Feb 28, 2025 | $2.10 |
| Mar 03, 2025 | $2.10 |
| Mar 04, 2025 | $2.10 |
| Mar 05, 2025 | $2.05 |
| 4 days before | 0% |
| 4 days after | -2.38% |
| On release day | 0% |
| Change in period | -2.38% |
| Release date | Aug 07, 2025 |
| Price on release | $3.05 |
| EPS estimate | - |
| EPS actual | $0.117 |
| Date | Price |
|---|---|
| Aug 01, 2025 | $2.80 |
| Aug 04, 2025 | $2.91 |
| Aug 05, 2025 | $2.81 |
| Aug 06, 2025 | $2.81 |
| Aug 07, 2025 | $3.05 |
| Aug 08, 2025 | $3.05 |
| Aug 11, 2025 | $3.05 |
| Aug 12, 2025 | $3.05 |
| Aug 13, 2025 | $3.05 |
| 4 days before | 9.12% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 9.12% |
| Release date | Mar 05, 2026 |
| Price on release | $4.05 |
| EPS estimate | - |
| EPS actual | $0.0732 |
| Date | Price |
|---|---|
| Feb 27, 2026 | $3.84 |
| Mar 02, 2026 | $4.05 |
| Mar 03, 2026 | $4.05 |
| Mar 04, 2026 | $4.05 |
| Mar 05, 2026 | $4.05 |
| Mar 06, 2026 | $4.00 |
| Mar 09, 2026 | $3.89 |
| Mar 10, 2026 | $4.35 |
| Mar 11, 2026 | $3.79 |
| 4 days before | 5.47% |
| 4 days after | -6.42% |
| On release day | -1.23% |
| Change in period | -1.30% |
Serco Group Earnings Call Transcript Summary of Q4 2025
Key investor takeaways from Serco's 2025 results:
- Financials: Revenue £4.9bn (+3% cc), underlying operating profit £272m (margin 5.6%), cash conversion 112%. Order intake £5.5bn (book-to-bill 114%). FY2026 guidance: revenue ~£5.0bn (organic ~3%), underlying operating profit ~£300m (margin ~6%), free cash flow ~£160m, adjusted net debt ~£165m. Dividend 4.5p (+8%) and a new £75m share buyback announced for H1 2026.
- Growth and pipeline: Defence is the main growth engine (c.40% of revenue), contributing ~£3.5bn of FY25 contract wins; group pipeline at a decade-high £12.1bn (with North America and UK/EU pipelines particularly strong). MT&S acquisition has been integrated rapidly and is already contributing to defence capability and early wins.
- Operational progress: Continued focus on three strategic pillars—growth, competitiveness and operational excellence—evidenced by maintained colleague engagement (70), a 22% reduction in safety incidents, >90% contract retention and productivity improvements across regions. APAC revenue down (post-Australia immigration contract exit and HK disposal) but margins improved via cost discipline.
- Cash & balance sheet: Strong cash generation and disciplined working capital: adjusted net debt £206m (year end), leverage 0.7x EBITDA (below target range). Capital allocation priorities: 1) organic growth, 2) disciplined M&A (bolt-ons), 3) returning surplus cash (dividend + buybacks).
- Risks & headwinds: Continued reductions in UK and Australian immigration activity are a near-term headwind (~3% organic drag expected), APAC needs further pipeline rebuild, and near-term U.S. decision delays (e.g., related to government shutdown effects) could slow timing of awards. Overall positioning is defensive given mission-critical services exposure and longer-term structural drivers in defence, immigration and citizen services.
